Showing results (71-80 of 1,860) with videos related to
Sort By:
Pageof 186
Journal of Medicinal Chemistry|September 1, 1985
Preparation of biologically active ristocetin derivatives: replacements of the 1'-amino groupT R Herrin, A M Thomas, T J Perun, et al.Biochemistry|September 22, 2000
NMR studies of the anti-apoptotic protein Bcl-xL in micellesJ A Losonczi, E T Olejniczak, S F Betz, et al.Biochemistry|December 29, 1992
A practical method for uniform isotopic labeling of recombinant proteins in mammalian cellsA P Hansen, A M Petros, A P Mazar, et al.Molecular and Cellular Biology|September 22, 1999
The BH3 domain of Bcl-x(S) is required for inhibition of the antiapoptotic function of Bcl-x(L)B S Chang, A Kelekar, M H Harris, et al.Science (New York, N.Y.)|February 14, 1997
Structure of Bcl-xL-Bak peptide complex: recognition between regulators of apoptosisM Sattler, H Liang, D Nettesheim, et al.Nature|June 23, 1994
Solution structure of a pleckstrin-homology domainH S Yoon, P J Hajduk, A M Petros, et al.Journal of Magnetic Resonance (San Diego, Calif. : 1997)|July 29, 1999
Accurate measurement of H(N)-H(alpha) residual dipolar couplings in proteinsM Cai, H Wang, E T Olejniczak, et al.Molecular Cell|August 19, 2000
14-3-3 proteins and survival kinases cooperate to inactivate BAD by BH3 domain phosphorylationS R Datta, A Katsov, L Hu, et al.The Journal of Biological Chemistry|October 11, 1996
Phosphatidylinositol 4,5-bisphosphate binding to the pleckstrin homology domain of phospholipase C-delta1 enhances enzyme activityJ W Lomasney, H F Cheng, L P Wang, et al.Nature|May 23, 1996
X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell deathS W Muchmore, M Sattler, H Liang, et al.Pageof 186